Literature DB >> 9828707

Epidemiology of hepatitis C virus infection in Nepal.

S M Shrestha1, N B Subedi, S Shrestha, K G Maharjan, F Tsuda, H Okamoto.   

Abstract

Prevalence of hepatitis C virus (HCV) infection in Nepal was studied by assaying sera from different population groups for anti-HCV by the second generation enzyme immunoassay method and for HCV RNA by polymerase chain reaction. The anti-HCV was positive in 0.6% of 2,860 healthy adults. HCV infection was responsible for 1.3% of acute viral hepatitis. Only drug addicts (DA) are known to have a very high incidence of the infection. The number of intravenous drug abusers (IDA) in Nepal have increased considerably since 1991 when buprenorphine (tidigesic) was introduced in the local market. About 72% of the drug addicts were found to be IDA and 94% of the IDA were anti-HCV positive. It is concluded that though the prevalence of HCV infection in the community is low, and at present it accounts for only a small number of acute and chronic liver diseases, the presence of a large number of DA in the country with high incidence of HCV infection may result in the emergence of HCV as an important cause of chronic liver disease in Nepal in future.

Entities:  

Mesh:

Year:  1998        PMID: 9828707

Source DB:  PubMed          Journal:  Trop Gastroenterol        ISSN: 0250-636X


  7 in total

Review 1.  Non-injection drug use and Hepatitis C Virus: a systematic review.

Authors:  Roberta Scheinmann; Holly Hagan; Corina Lelutiu-Weinberger; Rebecca Stern; Don C Des Jarlais; Peter L Flom; Shiela Strauss
Journal:  Drug Alcohol Depend       Date:  2006-12-15       Impact factor: 4.492

2.  The explosive human immunodeficiency virus type 1 epidemic among injecting drug users of Kathmandu, Nepal, is caused by a subtype C virus of restricted genetic diversity.

Authors:  R B Oelrichs; I L Shrestha; D A Anderson; N J Deacon
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Seroprevalence of HBV and HCV in blood donors: A study from regional blood transfusion services of Nepal.

Authors:  B R Tiwari; P Ghimire; S R Kandel; M Rajkarnikar
Journal:  Asian J Transfus Sci       Date:  2010-07

Review 4.  Liver Cancer in Nepal.

Authors:  Ananta Shrestha
Journal:  Euroasian J Hepatogastroenterol       Date:  2018-05-01

5.  Prevalence of HIV, Hepatitis B and C Infections and an Assessment of HCV-Genotypes and Two IL28B SNPs among People Who Inject Drugs in Three Regions of Nepal.

Authors:  Hans-Tilmann Kinkel; Dibesh Karmacharya; Jivan Shakya; Sulochana Manandhar; Santosh Panthi; Prajwola Karmacharya; Deepika Sitaula; Reenu Thapaliya; Prawachan K C; Apurva Rai; Sameer Dixit
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

Review 6.  Viral Hepatitis in Nepal: Past, Present, and Future.

Authors:  Ananta Shrestha
Journal:  Euroasian J Hepatogastroenterol       Date:  2016-07-09

7.  Direct-Acting Antivirals in the Treatment of Hepatitis C Virus (HCV)/Human Immunodeficiency Virus (HIV) Co-infected Patients: Real-Life Experience From Nepal.

Authors:  Sudhamshu Kc; Niyanta Karki; Dilip Sharma; Sandip Khadka; Pratap S Tiwari
Journal:  Cureus       Date:  2021-06-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.